DE68918279D1 - Plasminogenaktivator-varianten und verfahren zu ihrer herstellung. - Google Patents

Plasminogenaktivator-varianten und verfahren zu ihrer herstellung.

Info

Publication number
DE68918279D1
DE68918279D1 DE68918279T DE68918279T DE68918279D1 DE 68918279 D1 DE68918279 D1 DE 68918279D1 DE 68918279 T DE68918279 T DE 68918279T DE 68918279 T DE68918279 T DE 68918279T DE 68918279 D1 DE68918279 D1 DE 68918279D1
Authority
DE
Germany
Prior art keywords
variants
plasminogen activator
production
glycosylated
prepared
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE68918279T
Other languages
English (en)
Other versions
DE68918279T2 (de
Inventor
Stephen Anderson
Bruce Keyt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genentech Inc
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of DE68918279D1 publication Critical patent/DE68918279D1/de
Application granted granted Critical
Publication of DE68918279T2 publication Critical patent/DE68918279T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • C12N9/6459—Plasminogen activators t-plasminogen activator (3.4.21.68), i.e. tPA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE68918279T 1988-05-20 1989-05-04 Plasminogenaktivator-varianten und verfahren zu ihrer herstellung. Expired - Lifetime DE68918279T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19690988A 1988-05-20 1988-05-20
PCT/US1989/001947 WO1989011531A1 (en) 1988-05-20 1989-05-04 Variants of plasminogen activators and processes for their production

Publications (2)

Publication Number Publication Date
DE68918279D1 true DE68918279D1 (de) 1994-10-20
DE68918279T2 DE68918279T2 (de) 1995-03-23

Family

ID=22727245

Family Applications (1)

Application Number Title Priority Date Filing Date
DE68918279T Expired - Lifetime DE68918279T2 (de) 1988-05-20 1989-05-04 Plasminogenaktivator-varianten und verfahren zu ihrer herstellung.

Country Status (12)

Country Link
EP (1) EP0424405B1 (de)
JP (1) JP2928798B2 (de)
AT (1) ATE111525T1 (de)
AU (1) AU624158B2 (de)
CA (1) CA1341432C (de)
DE (1) DE68918279T2 (de)
DK (1) DK175938B1 (de)
ES (1) ES2013500A6 (de)
HK (1) HK1007333A1 (de)
IL (1) IL90146A (de)
NZ (1) NZ229081A (de)
WO (1) WO1989011531A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5098840A (en) * 1986-07-03 1992-03-24 The Green Cross Corporation Human prourokinase mutants
US5218092A (en) * 1988-09-29 1993-06-08 Kyowa Hakko Kogyo Co., Ltd. Modified granulocyte-colony stimulating factor polypeptide with added carbohydrate chains
FI895899A0 (fi) * 1988-12-12 1989-12-11 Yamanouchi Pharma Co Ltd Nya trombolytiska proteiner, foerfarande foer deras framstaellning och dessa som aktivaemne innehaollande laekemedel.
JPH0387180A (ja) * 1989-05-18 1991-04-11 Green Cross Corp:The 変異ヒトプロウロキナーゼ、その製法、ｄｎａ配列、プラスミド、宿主
AU645344B2 (en) * 1990-07-31 1994-01-13 Genentech Inc. Tissue plasminogen activator variants with decreased clearance
US5246850A (en) * 1990-07-31 1993-09-21 Genentech, Inc. DNA molecules encoding human tissue plasminogen activator variants with decreased clearance, vectors, and host cells
US5242688A (en) * 1990-12-24 1993-09-07 Eli Lilly And Company Method of treating thromboembolic disorders by administration of diglycosylated t-pa variants
US5595736A (en) * 1991-04-22 1997-01-21 Eli Lilly And Company Compounds and methods for treatment of thromboembolic disorders
US5223408A (en) * 1991-07-11 1993-06-29 Genentech, Inc. Method for making variant secreted proteins with altered properties
DK0643772T3 (da) * 1992-06-03 1998-02-02 Genentech Inc Glycosyleringsvarianter af vævsplasminogenaktivator med forbedrede terapeutiske egenskaber
US5945432A (en) * 1995-12-22 1999-08-31 The University Of Vermont And State Agricultural College Thrombolytic agents and thienopyridine derivatives in acute stroke
US7553930B2 (en) 2003-01-06 2009-06-30 Xencor, Inc. BAFF variants and methods thereof
EP1711533B1 (de) * 2004-01-14 2013-12-11 Ohio University Verfahren zur Herstellung von Peptiden/Proteinen in Pflanzen und dadurch hergestellte Peptide/Proteine

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8528321D0 (en) * 1985-11-18 1985-12-24 Ciba Geigy Ag Modified fibrinolytic agents
DE3684680D1 (de) * 1985-12-23 1992-05-07 Chiron Corp Peptidplasminogenaktivatoren.
DK43387A (da) * 1986-01-29 1987-07-30 Beecham Group Plc Fibrinolytisk enzym
AU7090787A (en) * 1986-02-19 1987-10-08 Beecham Group Plc Tissue plasminogen activator
IE81073B1 (en) * 1986-03-18 2000-01-12 Genentech Inc Modified human tissue-type plasminogen activator and its preparation

Also Published As

Publication number Publication date
AU3744889A (en) 1989-12-12
IL90146A0 (en) 1989-12-15
WO1989011531A1 (en) 1989-11-30
JPH03504327A (ja) 1991-09-26
DE68918279T2 (de) 1995-03-23
CA1341432C (en) 2003-06-17
DK175938B1 (da) 2005-07-25
ES2013500A6 (es) 1990-05-01
EP0424405A1 (de) 1991-05-02
JP2928798B2 (ja) 1999-08-03
ATE111525T1 (de) 1994-09-15
IL90146A (en) 1994-10-07
EP0424405B1 (de) 1994-09-14
NZ229081A (en) 1991-03-26
HK1007333A1 (en) 1999-04-09
DK274990A (da) 1991-01-18
DK274990D0 (da) 1990-11-19
AU624158B2 (en) 1992-06-04

Similar Documents

Publication Publication Date Title
DE3855523T2 (de) Proteine mit Faktor-VIII-Aktivität, Verfahren zu deren Herstellung unter Verwendung von genetisch modifizierten Zellen und diese enthaltende pharmazeutische Zusammensetzungen
DE68918279D1 (de) Plasminogenaktivator-varianten und verfahren zu ihrer herstellung.
ATE110782T1 (de) Rekombinanter menschlicher endothelzellenwachstumsfaktor.
IT1206311B (it) Agente terapeutico a base di oligonucleotide e metodi per laproduzione dello stesso.
NO178687C (no) Fremgangsmåte for fremstilling av forenlige, lagringsstabile erythropoietinpreparater
NL970008I2 (nl) Derivaat van een weefselplasminogeenactivator.
ATE135375T1 (de) Glykosaminoglykan-modifiertes protein, verfahren zu dessen herstellung und pharmazeutische zubereitungen, die es enthalten
PT80300A (de) Herstellung von polypeptiden mit human-gammainterferonaktivitat
DK215287A (da) Dna-sekvenser, der koder for et protein med angiogen virkning, vektorer, vaertsceller og fremgangsmaader til udtrykkelse af proteinet, samt laegemidler indeholdende dette
KR900002795A (ko) 하이브리드 단백질c 작제물 및 그들의 제조방법
ES2037136T3 (es) Procedimiento para la preparacion de una solucion con elevada actividad volumetrica de una proteina con actividad de activador de plasminogeno de tejidos (t-pa).
ATE88500T1 (de) Dna-sequenzen, die fuer proteine mit der biologischen aktivitaet der husi-typi-inhibitoren codieren, gentechnologische verfahren zur herstellung dieser proteine und diese proteine enthaltende arzneimittel.
ATE98868T1 (de) Topisch kosmetisch anzuwendende depolymerisierte nukleinsaeuren enthaltende arzneizubereitungen.
Zeldin et al. Acrylamide electrophoresis and protein pattern during morphogenesis in a slime mould
EP0315118A3 (de) Endothelin kodierendes DNA und dessen Verwendung
DE69014541T2 (de) Chemisch modifizierte Allergene und Verfahren zu ihrer Herstellung.
DK0542869T3 (da) Vævsplasminogenaktivatorvarianter med nedsat udskillelse
ES2033295T3 (es) Un metodo para preparar un activador de plasminogeno.
KR910016339A (ko) Pp4-델타, 이의 제조방법 및 용도

Legal Events

Date Code Title Description
8364 No opposition during term of opposition